Skip Navigation


Brain Advance Access originally published online on September 7, 2006
Brain 2006 129(11):2966-2976; doi:10.1093/brain/awl237
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
129/11/2966    most recent
awl237v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cabrejo, L.
Right arrow Articles by Hannequin, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cabrejo, L.
Right arrow Articles by Hannequin, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Phenotype associated with APP duplication in five families

Lucie Cabrejo1,*, Lucie Guyant-Maréchal1,2,3,*, Annie Laquerrière4, Martine Vercelletto5, François De La Fournière6, Catherine Thomas-Antérion7, Christophe Verny8, Franck Letournel9, Florence Pasquier10, Anne Vital11, Frédéric Checler12, Thierry Frebourg2,3, Dominique Campion2 and Didier Hannequin1,2,3

1 Department of Neurology, University Hospital IFRMP 2 Inserm U614, Faculty of Medicine IFRMP 3 Department of Genetics, University Hospital Rouen 4 Department of Neuropathology, University Hospital Rouen 5 Department of Neurology, University Hospital Nantes 6 Department of Geriatry CHG Pau 7 Department of Neurology, University Hospital Saint-Etienne 8 Department of Neurology, University Hospital Angers 9 Laboratoire de Biologie Cellulaire, University Hospital Angers 10 Department of Neurology and EA2691, University Hospital Lille 11 Department of Pathology, University Hospital Bordeaux 12 Institut de Pharmacologie Moleculaire et Cellulaire, UMR6097 CNRS/UNSA, Equipe labellisée Fondation pour la Recherche Médicale Valbonne, France

Correspondence to: Didier Hannequin, Department of Neurology, 1 rue de Germont, 76031 Rouen, Cedex, France E-mail: Didier.hannequin{at}chu-rouen.fr

Different duplications of the APP locus have been identified in five families with autosomal dominant early onset Alzheimer's disease (ADEOAD) and Aß-related cerebral amyloid angiopathy (CAA). This study describes the phenotype of this new entity. Clinical, neuropsychological, imagery and neuropathological data were reviewed. The phenotype was not dependent on the size of the duplication and there was no clinical feature of Down's syndrome. Dementia was observed in all cases; intracerebral haemorrhage (ICH) was reported in 6 (26%) and seizures occurred in 12 (57%) of 21 patients. Age of onset of dementia ranged from 42 to 59 years, ICH from 53 to 64 years and age at death from 46 to 75 years. The neuropathological findings in five cases demonstrated Alzheimer's disease and severe CAA lesions that were reminiscent from those reported in brains of Down's syndrome patients. A striking feature consisted in intraneuronal Aßx-40 accumulation located in the granular cell layer of the dentate gyrus and in the pyramidal cell layer of the Ammon's horn.

Key Words: amyloid angiopathy; Alzheimer's disease; APP duplication; Down's syndrome; intracerebral haemorrhage

Abbreviations: Aß, amyloid ß peptides; ADEOAD, autosomal dominant early onset Alzheimer's disease; BG, basal ganglia; CAA, cerebral amyloid angiopathy; HE, haematoxylin–eosin; ICH, intracerebral haemorrhage; WMC, white matter changes

.

Received July 10, 2006. Revised August 4, 2006. Accepted August 8, 2006.


*These authors have contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
D. W. Shineman, B. Zhang, S. N. Leight, D. Pratico, and V. M.-Y. Lee
Thromboxane Receptor Activation Mediates Isoprostane-Induced Increases in Amyloid Pathology in Tg2576 Mice
J. Neurosci., April 30, 2008; 28(18): 4785 - 4794.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. M. Remes, L. Laru, H. Tuominen, S. Aalto, N. Kemppainen, H. Mononen, K. Nagren, R. Parkkola, and J. O. Rinne
Carbon 11-Labeled Pittsburgh Compound B Positron Emission Tomographic Amyloid Imaging in Patients With APP Locus Duplication
Arch Neurol, April 1, 2008; 65(4): 540 - 544.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Rovelet-Lecrux, T Frebourg, H Tuominen, K Majamaa, D Campion, and A M Remes
APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage
J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1158 - 1159.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.